• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

双能 X 射线吸收法和肥胖指数是评估多囊卵巢综合征和正常体重指数女性中心性脂肪堆积的敏感方法。

Dual-energy X-ray absorptiometry and adiposity index are sensitive methods to evaluate central fat accumulation in women with polycystic ovary syndrome and normal body mass index.

机构信息

Setor de Reprodução Humana, Departamento de Ginecologia e Obstetrícia, Faculdade de Medicina de Ribeirão Preto, Universidade de São Paulo, Ribeirão Preto, SP, Brasil,

Instituto Federal de São Paulo, campus Jacareí, Jacareí, SP, Brasil.

出版信息

Arch Endocrinol Metab. 2023 May 25;67(5):e000627. doi: 10.20945/2359-3997000000627.

DOI:10.20945/2359-3997000000627
PMID:37249458
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10665059/
Abstract

OBJECTIVE

This study aimed to determine the differences in body fat distribution and central obesity indicators using dual-energy X-ray absorptiometry (DXA), adiposity indices, and anthropometric indices between women with and without polycystic ovary syndrome (PCOS).

MATERIALS AND METHODS

Clinical and laboratory examination history, including transvaginal ultrasound, fasting blood samples, anthropometric measurements, and DXA scans were conducted in 179 women with PCOS (PCOS group) and 100 without PCOS (non-PCOS group). The volunteers were grouped by body mass index (BMI): normal (18-24.9 kg/m), overweight (25-29.9 kg/m), or obese (>30 kg/m). The visceral adiposity index (VAI) and lipid accumulation product (LAP) were calculated, regions of interest (ROIs) were determined, and the fat mass index (FMI) was calculated using DXA.

RESULTS

VAI, LAP, ROIs, FMI, and adiposity indices by DXA were higher in women with PCOS and normal BMI. In both PCOS and non-PCOS groups, the ROIs progressively increased from normal BMI to overweight and obese, and from overweight to obese. Obese women with PCOS showed high trunk fat mass. However, obesity was not able to modify these trunk/periphery fat ratios in PCOS from overweight to higher BMI. These variables were associated with the incidence of PCOS.

CONCLUSION

In women with PCOS and normal BMI, both DXA and the adiposity indices, VAI and LAP, are more sensitive methods to evaluate total body fat and fat accumulation in the central abdominal region. It was also observed that as BMI increased, the differences in measurements between women with and without PCOS decreased.

摘要

目的

本研究旨在通过双能 X 射线吸收法(DXA)、肥胖指数和人体测量指数,比较多囊卵巢综合征(PCOS)患者和非 PCOS 患者的体脂分布和中心性肥胖指标的差异。

材料和方法

对 179 例 PCOS 患者(PCOS 组)和 100 例非 PCOS 患者(非 PCOS 组)进行了临床和实验室检查史,包括经阴道超声、空腹血样、人体测量和 DXA 扫描。志愿者按体重指数(BMI)分组:正常(18-24.9kg/m²)、超重(25-29.9kg/m²)或肥胖(>30kg/m²)。计算了内脏脂肪指数(VAI)和脂积指数(LAP),确定了感兴趣区域(ROI),并使用 DXA 计算了脂肪质量指数(FMI)。

结果

PCOS 且 BMI 正常的女性的 VAI、LAP、ROI、FMI 和 DXA 肥胖指数较高。在 PCOS 和非 PCOS 组中,ROI 从正常 BMI 到超重和肥胖、从超重到肥胖逐渐增加。肥胖的 PCOS 女性表现出高躯干脂肪量。然而,肥胖并不能改变 PCOS 从超重到更高 BMI 时躯干/外周脂肪比。这些变量与 PCOS 的发生有关。

结论

在 PCOS 且 BMI 正常的女性中,DXA 和肥胖指数、VAI 和 LAP 都是更敏感的方法,可以评估全身脂肪和中央腹部区域的脂肪堆积。还观察到,随着 BMI 的增加,PCOS 患者和非 PCOS 患者之间的测量值差异减小。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0f81/10665059/7b31cd419c0e/2359-4292-aem-67-05-e000627-gf02.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0f81/10665059/3c53314c5b8e/2359-4292-aem-67-05-e000627-gf01.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0f81/10665059/7b31cd419c0e/2359-4292-aem-67-05-e000627-gf02.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0f81/10665059/3c53314c5b8e/2359-4292-aem-67-05-e000627-gf01.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0f81/10665059/7b31cd419c0e/2359-4292-aem-67-05-e000627-gf02.jpg

相似文献

1
Dual-energy X-ray absorptiometry and adiposity index are sensitive methods to evaluate central fat accumulation in women with polycystic ovary syndrome and normal body mass index.双能 X 射线吸收法和肥胖指数是评估多囊卵巢综合征和正常体重指数女性中心性脂肪堆积的敏感方法。
Arch Endocrinol Metab. 2023 May 25;67(5):e000627. doi: 10.20945/2359-3997000000627.
2
Comparison of regional fat mass measurement by whole body DXA scans and anthropometric measures to predict insulin resistance in women with polycystic ovary syndrome and controls.通过全身双能X线吸收扫描和人体测量学方法测量局部脂肪量以预测多囊卵巢综合征女性及对照者胰岛素抵抗的比较。
Acta Obstet Gynecol Scand. 2016 Nov;95(11):1235-1243. doi: 10.1111/aogs.12964.
3
Association of measures of central fat accumulation indices with body fat distribution and metabolic, hormonal, and inflammatory parameters in women with polycystic ovary syndrome.多囊卵巢综合征女性中心性脂肪堆积指数测量值与体脂分布及代谢、激素和炎症参数的关联
Arch Endocrinol Metab. 2019 Jul 29;63(4):417-426. doi: 10.20945/2359-3997000000157.
4
Visceral adiposity index levels in overweight and/or obese, and non-obese patients with polycystic ovary syndrome and its relationship with metabolic and inflammatory parameters.超重和/或肥胖以及非肥胖多囊卵巢综合征患者的内脏脂肪指数水平及其与代谢和炎症参数的关系。
J Endocrinol Invest. 2017 May;40(5):487-497. doi: 10.1007/s40618-016-0582-x. Epub 2016 Nov 12.
5
The Visceral Adiposity Index (VAI) and Lipid Accumulation Product (LAP) Are Predictors of Insulin Resistance and Hyperandrogenaemia in Obesity/Overweight Women with Polycystic Ovary Syndrome.内脏脂肪指数(VAI)和脂类蓄积产物(LAP)是肥胖/超重多囊卵巢综合征妇女胰岛素抵抗和高雄激素血症的预测因子。
Biomed Res Int. 2023 Feb 13;2023:1508675. doi: 10.1155/2023/1508675. eCollection 2023.
6
Body fat indices as effective predictors of insulin resistance in obese/non-obese polycystic ovary syndrome women in the Southwest of China.中国西南地区肥胖/非肥胖多囊卵巢综合征女性体脂指数作为胰岛素抵抗的有效预测指标。
Endocrine. 2019 Jul;65(1):81-85. doi: 10.1007/s12020-019-01912-1. Epub 2019 Mar 28.
7
Indirect Predictors of Visceral Adipose Tissue in Women with Polycystic Ovary Syndrome: A Comparison of Methods.多囊卵巢综合征女性内脏脂肪组织的间接预测指标:方法比较。
Nutrients. 2021 Jul 22;13(8):2494. doi: 10.3390/nu13082494.
8
Lipid Accumulation Product (LAP) and Visceral Adiposity Index (VAI) as Markers of Insulin Resistance and Metabolic Associated Disturbances in Young Argentine Women with Polycystic Ovary Syndrome.脂质蓄积产物(LAP)和内脏脂肪指数(VAI)作为阿根廷多囊卵巢综合征年轻女性胰岛素抵抗和代谢相关紊乱标志物的研究
Horm Metab Res. 2017 Jan;49(1):23-29. doi: 10.1055/s-0042-113463. Epub 2016 Aug 29.
9
Comparison of Central Fat Accumulation Indices with Body Mass Index in Women with Polycystic Ovary Syndrome.多囊卵巢综合征女性中心性脂肪堆积指数与体重指数的比较
J Obstet Gynaecol India. 2023 Oct;73(Suppl 1):156-160. doi: 10.1007/s13224-023-01834-z. Epub 2023 Sep 20.
10
Estimation of truncal adiposity using waist circumference or the sum of trunk skinfolds: a pilot study for insulin resistance screening in hirsute patients with or without polycystic ovary syndrome.使用腰围或躯干皮褶厚度总和估算躯干肥胖:一项针对有或无多囊卵巢综合征的多毛症患者进行胰岛素抵抗筛查的初步研究。
Metabolism. 2007 Jul;56(7):992-7. doi: 10.1016/j.metabol.2007.03.006.

引用本文的文献

1
Visceral obesity anthropometric indicators as predictors of acute pancreatitis severity.内脏肥胖人体测量指标作为急性胰腺炎严重程度的预测指标。
Front Med (Lausanne). 2025 Jul 11;12:1536090. doi: 10.3389/fmed.2025.1536090. eCollection 2025.
2
Association between visceral adiposity index and cancer risk in the UK Biobank cohort.英国生物银行队列中内脏脂肪指数与癌症风险的关联。
Cancer. 2025 Jan 1;131(1):e35576. doi: 10.1002/cncr.35576. Epub 2024 Oct 3.
3
Association of Aldosterone, Renin, and Aldosterone to Renin Ratio with Metabolic Profile in Primary Aldosteronism.

本文引用的文献

1
Effect of Sex Hormone-Binding Globulin on Polycystic Ovary Syndrome: Mechanisms, Manifestations, Genetics, and Treatment.性激素结合球蛋白对多囊卵巢综合征的影响:机制、表现、遗传学及治疗
Int J Womens Health. 2022 Feb 2;14:91-105. doi: 10.2147/IJWH.S344542. eCollection 2022.
2
The Role of Visceral Adiposity Index as Predictor of Metabolic Syndrome in Obese and Nonobese Women with Polycystic Ovary Syndrome.内脏脂肪指数在肥胖和非肥胖多囊卵巢综合征妇女代谢综合征预测中的作用。
Metab Syndr Relat Disord. 2021 Feb;19(1):18-25. doi: 10.1089/met.2020.0045. Epub 2020 Aug 25.
3
The relationship between sex steroids, insulin resistance and body compositions in obese women: A case-control study.
原发性醛固酮增多症中醛固酮、肾素及醛固酮与肾素比值与代谢谱的关联
Diabetes Metab Syndr Obes. 2024 May 18;17:2065-2074. doi: 10.2147/DMSO.S457243. eCollection 2024.
4
Relationship between SIRI and android and gynoid fat related to obesity and cardiovascular risk: a cross-sectional study of NHANES 2017-2018.SIRI 与 android 和女性型肥胖相关脂肪与肥胖和心血管风险的关系:NHANES 2017-2018 的横断面研究。
J Int Med Res. 2024 Mar;52(3):3000605241239841. doi: 10.1177/03000605241239841.
肥胖女性体内性类固醇、胰岛素抵抗与身体成分之间的关系:一项病例对照研究。
J Med Biochem. 2020 Jan 10;39(1):25-31. doi: 10.2478/jomb-2019-0009.
4
Obesity and Polycystic Ovary Syndrome: Implications for Pathogenesis and Novel Management Strategies.肥胖与多囊卵巢综合征:对发病机制及新型管理策略的影响
Clin Med Insights Reprod Health. 2019 Sep 9;13:1179558119874042. doi: 10.1177/1179558119874042. eCollection 2019.
5
Obesity and Androgens in Women.女性肥胖与雄激素。
Front Horm Res. 2019;53:120-134. doi: 10.1159/000494908. Epub 2019 Sep 9.
6
Anthropometric and body composition analysis of infertile women with polycystic ovary syndrome.多囊卵巢综合征不孕女性的人体测量与身体成分分析
J Taibah Univ Med Sci. 2017 Jan 13;12(2):139-145. doi: 10.1016/j.jtumed.2016.11.005. eCollection 2017 Apr.
7
Association of measures of central fat accumulation indices with body fat distribution and metabolic, hormonal, and inflammatory parameters in women with polycystic ovary syndrome.多囊卵巢综合征女性中心性脂肪堆积指数测量值与体脂分布及代谢、激素和炎症参数的关联
Arch Endocrinol Metab. 2019 Jul 29;63(4):417-426. doi: 10.20945/2359-3997000000157.
8
Effects of Progressive Resistance Training on Obesity Indices in Polycystic Ovary Syndrome and the Relationship With Telomere Length.渐进性抗阻训练对多囊卵巢综合征肥胖指数的影响及其与端粒长度的关系。
J Phys Act Health. 2019 Aug 1;16(8):601-607. doi: 10.1123/jpah.2018-0256.
9
Dyslipidemia involvement in the development of polycystic ovary syndrome.脂代谢紊乱与多囊卵巢综合征的发生发展。
Taiwan J Obstet Gynecol. 2019 Jul;58(4):447-453. doi: 10.1016/j.tjog.2019.05.003.
10
Body Composition, Metabolic Characteristics, and Insulin Resistance in Obese and Nonobese Women with Polycystic Ovary Syndrome.肥胖和非肥胖多囊卵巢综合征女性的身体成分、代谢特征及胰岛素抵抗
J Hum Reprod Sci. 2019 Apr-Jun;12(2):78-84. doi: 10.4103/jhrs.JHRS_2_19.